ID
12644
Description
Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor; ODM derived from: https://clinicaltrials.gov/show/NCT01362985
Link
https://clinicaltrials.gov/show/NCT01362985
Keywords
Versions (1)
- 12/7/15 12/7/15 -
Uploaded on
December 7, 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Leukemia NCT01362985
Eligibility Acute Leukemia NCT01362985
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
adults diagnosed with lymphoma or multiple myeloma (mm) and have been treated with plerixafor
Data type
boolean
Alias
- UMLS CUI [1]
- C0001675
- UMLS CUI [2]
- C0024299
- UMLS CUI [3]
- C0026764
- UMLS CUI [4]
- C1955474
Similar models
Eligibility Acute Leukemia NCT01362985
- StudyEvent: Eligibility
C0205394 (UMLS CUI [2])
C0024299 (UMLS CUI [3])
C0026764 (UMLS CUI [4])
C1301624 (UMLS CUI [2])
C1955474 (UMLS CUI [2])
C0411265 (UMLS CUI [3])
C1955474 (UMLS CUI [2])
C0411265 (UMLS CUI [3])
C0205394 (UMLS CUI [2])
C1522438 (UMLS CUI [3])
C0024299 (UMLS CUI [2])
C0026764 (UMLS CUI [3])
C1955474 (UMLS CUI [4])